These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20811885)

  • 1. Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogen.
    Khan ST; Pixley RA; Liu Y; Bakdash N; Gordon B; Agelan A; Huang Y; Achary MP; Colman RW
    Cancer Immunol Immunother; 2010 Dec; 59(12):1885-93. PubMed ID: 20811885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen.
    Song JS; Sainz IM; Cosenza SC; Isordia-Salas I; Bior A; Bradford HN; Guo YL; Pixley RA; Reddy EP; Colman RW
    Blood; 2004 Oct; 104(7):2065-72. PubMed ID: 15161672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen.
    Colman RW; Pixley RA; Sainz IM; Song JS; Isordia-Salas I; Muhamed SN; Powell JA; Mousa SA
    J Thromb Haemost; 2003 Jan; 1(1):164-70. PubMed ID: 12871554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen.
    Sainz IM; Isordia-Salas I; Espinola RG; Long WK; Pixley RA; Colman RW
    Cancer Immunol Immunother; 2006 Jul; 55(7):797-807. PubMed ID: 16187087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
    Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
    Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen.
    Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1887-94. PubMed ID: 12489802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    de Aguiar RB; Parise CB; Souza CR; Braggion C; Quintilio W; Moro AM; Navarro Marques FL; Buchpiguel CA; Chammas R; de Moraes JZ
    Cancer Lett; 2016 Feb; 371(2):151-60. PubMed ID: 26655277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
    Yang JH; Hu J; Wan L; Chen LJ
    Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
    Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
    Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contact system and angiogenesis: potential for therapeutic control of malignancy.
    Colman RW
    Semin Thromb Hemost; 2004 Feb; 30(1):45-61. PubMed ID: 15034797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis by the kallikrein-kinin system.
    Colman RW
    Curr Pharm Des; 2006; 12(21):2599-607. PubMed ID: 16842160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat.
    Keith JC; Sainz IM; Isordia-Salas I; Pixley RA; Leathurby Y; Albert LM; Colman RW
    Arthritis Res Ther; 2005; 7(4):R769-76. PubMed ID: 15987478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
    Naglich JG; Jure-Kunkel M; Gupta E; Fargnoli J; Henderson AJ; Lewin AC; Talbott R; Baxter A; Bird J; Savopoulos R; Wills R; Kramer RA; Trail PA
    Cancer Res; 2001 Dec; 61(23):8480-5. PubMed ID: 11731431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5).
    Wachtfogel YT; DeLa Cadena RA; Kunapuli SP; Rick L; Miller M; Schultze RL; Altieri DC; Edgington TS; Colman RW
    J Biol Chem; 1994 Jul; 269(30):19307-12. PubMed ID: 8034694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461.
    Sato K; Yoo YC; Mochizuki M; Saiki I; Takahashi TA; Azuma I
    Jpn J Cancer Res; 1995 Apr; 86(4):374-82. PubMed ID: 7539783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.
    Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y
    Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
    Kolber DL; Knisely TL; Maione TE
    J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
    McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
    Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
    Yang H; Jager MJ; Grossniklaus HE
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2835-42. PubMed ID: 20089875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.